Dynamic urinary proteomics integrates single-cell and spatial transcriptomics to reveal tumour microenvironment and predict immunotherapy response in biliary tract cancer - Takeaways - MDSpire

Dynamic urinary proteomics integrates single-cell and spatial transcriptomics to reveal tumour microenvironment and predict immunotherapy response in biliary tract cancer

  • By

  • Shanshan Wang

  • Zhengguang Guo

  • Boyu Sun

  • Kai Liu

  • Jiashuo Chao

  • Ziyu Xun

  • Yunchao Wang

  • Zibo Xu

  • Ziyue Huang

  • Hao Wang

  • Yang Tan

  • Nan Zhang

  • Mingjian Piao

  • Longhao Zhang

  • Chengjie Li

  • Shuofeng Li

  • Jiongyuan Li

  • Haidan Sun

  • Feng Qi

  • Aiwei Wang

  • XiaoBo Yang

  • Chengpei Zhu

  • Hanping Wang

  • Wei Sun

  • Haitao Zhao

  • July 1, 2026

  • 0 min

Share

  • 1

    Urinary proteomics provides a non-invasive method to predict immune checkpoint inhibitor responsiveness in biliary tract cancer.

  • 2

    Protein tyrosine phosphatase non-receptor 13 is identified as a potential biomarker and therapeutic target for improving immunotherapy outcomes.

  • 3

    The study integrates urinary proteomics with single-cell and spatial transcriptomics to reveal insights into the tumor microenvironment.

  • 4

    Urinary proteomic profiling may enable timely therapeutic adjustments and enhance the application of liquid biopsies in immuno-oncology.

  • 5

    This research highlights the need for dynamic biomarkers to monitor immune-tumor interactions and predict responses to immunotherapy.

Original Source(s)

Related Content